Please assess the completion status of the following clinical trial:

Trial Title: Utilizing MRI to Study the Effect of Sulforaphane on Prostate Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Suitable for and have chosen AS as management for localised prostate cancer~* MRI visible detected lesion ≥0.5 cm in the axial plane, corresponding to the biopsy confirmed region of prostate cancer~* No contraindication to MR scanning~* Aged 18-80 years~* BMI between 19.5 and 35 kg/m2~* Smokers and non-smokers~Exclusion Criteria:~* 5α-reductase inhibitors or testosterone replacement medicines~* warfarin~* surgically implanted pelvic metalwork~* pacemakers or other implanted electronic devices not compatible with MRI~* contra-indications to gadolinium-based contrast agents (including patients with abnormal renal function)~* Glomerular Filtration Rate (GFR) \<60 ml/min~* claustrophobia~* allergies to any of the ingredients of the broccoli soups~* dietary supplements or herbal remedies which may affect the study outcome - unless the volunteer is willing to discontinue taking them for 1 month prior to starting study~* parallel participation in another research project that involves dietary intervention

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- standard broccoli soup (Type: ACTIVE_COMPARATOR): one portion (300 g each) per week of a soup containing standard broccoli
- beneforte extra broccoli soup (Type: EXPERIMENTAL): one portion (300 g each) per week of a soup containing glucoraphanin-enriched broccoli named for the study 'Beneforte extra'

Based on this trial design, predict the completion outcome and termination type (if applicable).